Back to News
Market Impact: 0.12
Jasper Therapeutics Appoints Regulatory, Clinical Executives For Pipeline Development; Stock Up
Source: Nasdaq
Healthcare & BiotechManagement & Governance
Jasper Therapeutics appointed Lisa Pitt as Senior Vice President of Regulatory Affairs and Shiguang Liu as Vice President of Clinical Development. The leadership additions bolster regulatory and clinical-development capabilities at the clinical-stage immune-mediated disease biotech, but no trial, financial, or guidance update was disclosed.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.15
Ticker Sentiment
JSPR0.25
More News
- ASML’s CEO is putting his paycheck on the line for employee morale. It could help retain talent that’s nearly impossible to replace
- ‘Like Kashmir’: How a toxic marble dump yard became a tourist spot in India
- Apple CEO says the company doesn’t ‘want to ship AI for AI’s sake’
- Swiss firms plan to expand China investments as trade deal deepens ties
- Citi explains what ’hawk’ and ’dove’ really mean as ECB faces leadership change
- The ex-CEO of the agency behind ‘Jerry Maguire’ says NIL is still the Wild West—and parents are part of the problem